Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial - Concepedia

Concepedia

Publication | Open Access

Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial

DOI Full Paper Access

445

Citations

23

References

2016

Year

Fred Lublin, David H. Miller, Mark S. Freedman, Bruce Cree, Jerry S. Wolinsky, Howard L. Weiner, Catherine Lubetzki, Hans‐Peter Hartung, Xavier Montalbán, Bernard M.J. Uitdehaag,

Oral FingolimodNeurological DisorderClinical NeurologyClinical TrialsOral MedicinePlacebo-controlled TrialNeurologyMultiple SclerosisMedicineNeuroimmunologyPhase 3Health Sciences

References

	Year	Citations

Page 1

Page 1